Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Keiko who wrote (8225)	2/25/1998 8:36:00 AM
From: AgAuUSA	Read Replies (3) \| Respond to of 14328

Keiko, The CDC appears to be favoring rapid tests over machine due to studies that show the time from transmission to disease is important. TIME is a factor in occupational transmission due to needle stick. A rapid test would prevent the need to transfer the patient to a lab for blood draw, transport of blood to the testing lab, and receipt of the result 1-3w later. Thus, a rapid test may eliminate preventive Rx tx of the needle stick person due to the time lag. Studies shoe that immediate tx with anti-HIV drugs can prevent HIV transmission due to exposure. Additionally, psychological factors, employee time off work and disruption of lives may also be saved. Studies show that TIME is the critical factor in interception of HIV+ persons to full blown AIDS development. Early, multidrug treatment can even prevent the development of most HIV symptomatology. People have been shown to survive indefinately when treated early. Thus, physicians and patients want early diagnosis and treatment. Additionally, a 2-4 week lag due to laboratory testing can prove critical to disease transmission to the unborn. I strongly suspect that the POC standard of care for screening testing for HIV and other diseases will become rapid type tests. The cost savings and rapid results will insure that rapid tests penetrate further into the market.